Väestöliitto
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
2009 · Jorma Paavonen, Paulo Naud, et al. · The Lancet
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
2007 · Jorma Paavonen, David Jenkins, et al. · The Lancet
Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA–binding protein gene
1995 · Renee A. Reijo Pera, Tien-Yi Lee, et al. · Nature Genetics